Identification of C/EBPβ Target Genes in ALK+ Anaplastic Large Cell Lymphoma (ALCL) by Gene Expression Profiling and Chromatin Immunoprecipitation

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Jun 7

PMID 23741337

Citations 23

Authors

Irina Bonzheim

Martin Irmler

Margit Klier-Richter

Julia Steinhilber

Natasa Anastasov

Sabine Schafer

Patrick Adam

Johannes Beckers

Mark Raffeld

Falko Fend

Leticia Quintanilla-Martinez

Affiliations

Soon will be listed here.

Abstract

C/EBPβ (CCAAT enhancer binding protein) is a transcription factor that plays a crucial role in survival and transformation of ALK+ anaplastic large cell lymphoma (ALCL). The aim of this study was to identify the downstream targets of C/EBPβ responsible for ALK-mediated oncogenesis. C/EBPβ was knocked down in ALK+ ALCL cell lines with a C/EBPβ-shRNA, followed by gene expression profiling (GEP). GEP analysis revealed a reproducible signature of genes that were significantly regulated by C/EBPβ. Classification into biological categories revealed overrepresentation of genes involved in the immune response, apoptosis and cell proliferation. Transcriptional regulation by C/EBPβ was found in 6 of 11 (BCL2A1, G0S2, TRIB1, S100A9, DDX21 and DDIT4) genes investigated by chromatin immunoprecipitation. We demonstrated that BCL2A1, G0S2 and DDX21 play a crucial role in survival and proliferation of ALK+ ALCL cells. DDX21, a gene involved in rRNA biogenesis, was found differentially overexpressed in primary ALK+ ALCL cases. All three candidate genes were validated in primary ALCL cases by either immunohistochemistry or RT-qPCR. In conclusion, we identified and validated several key C/EBPβ-regulated genes with major impact on survival and cell growth in ALK+ ALCL, supporting the central role of C/EBPβ in ALK-mediated oncogenesis.

Citing Articles

Updates in pathobiological aspects of anaplastic large cell lymphoma.

Wu R, Lim M Front Oncol. 2023; 13:1241532.

PMID: 37810974 PMC: 10556522. DOI: 10.3389/fonc.2023.1241532.

Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells.

Pan Z, Zhang M, Zhang F, Pan H, Li Y, Shao Y Int J Mol Sci. 2023; 24(1).

PMID: 36613925 PMC: 9820263. DOI: 10.3390/ijms24010482.

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.

Gonzalez M, Olivas I, Bencomo-Alvarez A, Rubio A, Barreto-Vargas C, Lopez J Clin Transl Med. 2022; 12(12):e1146.

PMID: 36536477 PMC: 9763536. DOI: 10.1002/ctm2.1146.

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.

Hu A, Wang Y, Tian J, Chen Z, Chen R, Han X Front Oncol. 2022; 12:947054.

PMID: 36505822 PMC: 9730287. DOI: 10.3389/fonc.2022.947054.

CD147 a direct target of miR-146a supports energy metabolism and promotes tumor growth in ALK+ ALCL.

Montes-Mojarro I, Steinhilber J, Griessinger C, Rau A, Gersmann A, Kohlhofer U Leukemia. 2022; 36(8):2050-2063.

PMID: 35676454 PMC: 9343252. DOI: 10.1038/s41375-022-01617-x.

References

Zhu S, Yoon K, Sterneck E, Johnson P, Smart R . CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci U S A. 2002; 99(1):207-12. PMC: 117540. DOI: 10.1073/pnas.012437299. View

Nusse M, Beisker W, Kramer J, Miller B, Schreiber G, Viaggi S . Measurement of micronuclei by flow cytometry. Methods Cell Biol. 1994; 42 Pt B:149-58. DOI: 10.1016/s0091-679x(08)61072-9. View

Drexler H, MacLeod R . Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma. Leukemia. 2004; 18(10):1569-71. DOI: 10.1038/sj.leu.2403465. View

Specht K, Kremer M, Muller U, Dirnhofer S, Rosemann M, Hofler H . Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Clin Cancer Res. 2002; 8(9):2902-11. View

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Westermarck J, Weiss C, Saffrich R, Kast J, Wessely M, Ansorge W . The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. EMBO J. 2002; 21(3):451-60. PMC: 125820. DOI: 10.1093/emboj/21.3.451. View

Valdez B, Henning D, Perumal K, Busch H . RNA-unwinding and RNA-folding activities of RNA helicase II/Gu--two activities in separate domains of the same protein. Eur J Biochem. 1998; 250(3):800-7. DOI: 10.1111/j.1432-1033.1997.00800.x. View

Mandal M, Borowski C, Palomero T, Ferrando A, Oberdoerffer P, Meng F . The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med. 2005; 201(4):603-14. PMC: 2213063. DOI: 10.1084/jem.20041924. View

Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, Trajanoski Z . CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res. 2006; 34(Web Server issue):W498-503. PMC: 1538903. DOI: 10.1093/nar/gkl038. View

10.

Edelstein L, Lagos L, Simmons M, Tirumalai H, Gelinas C . NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1. Mol Cell Biol. 2003; 23(8):2749-61. PMC: 152543. DOI: 10.1128/MCB.23.8.2749-2761.2003. View

11.

Buck M, Poli V, Hunter T, Chojkier M . C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell. 2001; 8(4):807-16. DOI: 10.1016/s1097-2765(01)00374-4. View

12.

Klier M, Anastasov N, Hermann A, Meindl T, Angermeier D, Raffeld M . Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia. 2008; 22(11):2097-105. DOI: 10.1038/leu.2008.213. View

13.

Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno I . Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol. 2010; 28(9):1583-90. DOI: 10.1200/JCO.2008.20.9759. View

14.

Cimino D, Fuso L, Sfiligoi C, Biglia N, Ponzone R, Maggiorotto F . Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues. Int J Cancer. 2008; 123(6):1327-38. DOI: 10.1002/ijc.23660. View

15.

Yang H, Henning D, Valdez B . Functional interaction between RNA helicase II/Gu(alpha) and ribosomal protein L4. FEBS J. 2005; 272(15):3788-802. DOI: 10.1111/j.1742-4658.2005.04811.x. View

16.

Quintanilla-Martinez L, Pittaluga S, Miething C, Klier M, Rudelius M, Davies-Hill T . NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood. 2006; 108(6):2029-36. DOI: 10.1182/blood-2005-10-014258. View

17.

Koch I, Slotta-Huspenina J, Hollweck R, Anastasov N, Hofler H, Quintanilla-Martinez L . Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues. Diagn Mol Pathol. 2006; 15(3):149-56. DOI: 10.1097/01.pdm.0000213450.99655.54. View

18.

Bai R, Dieter P, Peschel C, Morris S, Duyster J . Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol. 1998; 18(12):6951-61. PMC: 109278. DOI: 10.1128/MCB.18.12.6951. View

19.

Ali S, Zaidi S, Dacwag C, Salma N, Young D, Shakoori A . Phenotypic transcription factors epigenetically mediate cell growth control. Proc Natl Acad Sci U S A. 2008; 105(18):6632-7. PMC: 2373311. DOI: 10.1073/pnas.0800970105. View

20.

Schambach A, Bohne J, Chandra S, Will E, Margison G, Williams D . Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther. 2005; 13(2):391-400. DOI: 10.1016/j.ymthe.2005.08.012. View